Aberathne, I., Kulasiri, D., Samarasinghe, S., Detection of Alzheimer's disease onset using MRI and PET neuroimaging: Longitudinal data analysis and machine learning. Neural Regeneration Research 18:10 (2023), 2134–2140, 10.4103/1673-5374.367840.
Andrews-Hanna, J.R., Reidler, J.S., Sepulcre, J., Poulin, R., Buckner, R.L., Functional-anatomic fractionation of the brain's default network. Neuron 65:4 (2010), 550–562, 10.1016/j.neuron.2010.02.005.
Antoine, N., Bahri, M.A., Bastin, C., Collette, F., Phillips, C., Balteau, E., Salmon, E., Anosognosia and default mode subnetwork dysfunction in Alzheimer's disease. Human Brain Mapping 40:18 (2019), 5330–5340, 10.1002/hbm.24775.
Apostolova, I., Lange, C., Maurer, A., Suppa, P., Spies, L., Grothe, M.J., Alzheimer's Disease Neuroimaging, I. Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation. Neurobiology of Aging 65 (2018), 41–50, 10.1016/j.neurobiolaging.2018.01.002.
Arbizu, J., Festari, C., Altomare, D., Walker, Z., Bouwman, F., Rivolta, J., Disorders, E.-E. T. F. f. t. P. o. F.-P. f. D. N. Clinical utility of FDG-PET for the clinical diagnosis in MCI. European Journal of Nuclear Medicine and Molecular Imaging 45:9 (2018), 1497–1508, 10.1007/s00259-018-4039-7.
Ashraf, A., Fan, Z., Brooks, D.J., Edison, P., Cortical hypermetabolism in MCI subjects: A compensatory mechanism?. European Journal of Nuclear Medicine and Molecular Imaging 42:3 (2015), 447–458, 10.1007/s00259-014-2919-z.
Aziz, A.L., Giusiano, B., Joubert, S., Duprat, L., Didic, M., Gueriot, C., Ceccaldi, M., Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease. Neurobiology of Aging 54 (2017), 22–30, 10.1016/j.neurobiolaging.2017.02.010.
Bastin, C., Bahri, M.A., Mievis, F., Lemaire, C., Collette, F., Genon, S., Salmon, E., Associative memory and its cerebral correlates in Alzheimers disease: Evidence for distinct deficits of relational and conjunctive memory. Neuropsychologia 63 (2014), 99–106, 10.1016/j.neuropsychologia.2014.08.023.
Bastin, C., Besson, G., Simon, J., Delhaye, E., Geurten, M., Willems, S., Salmon, E., An integrative memory model of recollection and familiarity to understand memory deficits. Behavioral and Brain Sciences, 42, 2019, e281, 10.1017/S0140525X19000621.
Bastin, C., Kerrouche, N., Lekeu, F., Adam, S., Guillaume, B., Lemaire, C., Salmon, E., Controlled memory processes in questionable Alzheimer's disease: A view from neuroimaging research. Journal of Alzheimer's Disease 20:2 (2010), 547–560.
Bateman, R.J., Xiong, C., Benzinger, T.L., Fagan, A.M., Goate, A., Fox, N.C., Dominantly Inherited Alzheimer, N. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine 367:9 (2012), 795–804, 10.1056/NEJMoa1202753.
Boccalini, C., Caminiti, S.P., Chiti, A., Frisoni, G.B., Garibotto, V., Perani, D., Alzheimer's Disease Neuroimaging, I. The diagnostic and prognostic value of tau-PET in amnestic MCI with different FDG-PET subtypes. Annals of Clinical and Translational Neurology 11:5 (2024), 1236–1249, 10.1002/acn3.52039.
Borchert, R.J., Azevedo, T., Badhwar, A., Bernal, J., Betts, M., Bruffaerts, R., Rittman, T., Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 19:12 (2023), 5885–5904, 10.1002/alz.13412.
Botha, H., Mantyh, W.G., Murray, M.E., Knopman, D.S., Przybelski, S.A., Wiste, H.J., Jones, D.T., FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain: a Journal of Neurology 141:4 (2018), 1201–1217, 10.1093/brain/awy049.
Buckner, R.L., Snyder, A.Z., Shannon, B.J., LaRossa, G., Sachs, R., Fotenos, A.F., Mintun, M.A., Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 25:34 (2005), 7709–7717.
Cabeza, R., Ciaramelli, E., Olson, I.R., Moscovitch, M., The parietal cortex and episodic memory: An attentional account. Nature Reviews. Neuroscience 9:8 (2008), 613–625.
Cabrera-Martin, M.N., Nespral, P., Valles-Salgado, M., Bascunana, P., Delgado-Alonso, C., Delgado-Alvarez, A., Matias-Guiu, J.A., FDG-PET-based neural correlates of Addenbrooke's cognitive examination III scores in Alzheimer's disease and frontotemporal degeneration. Frontiers in Psychology, 14, 2023, 1273608, 10.3389/fpsyg.2023.1273608.
Caminiti, S.P., Ballarini, T., Sala, A., Cerami, C., Presotto, L., Santangelo, R., Project, B. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage: Clinical 18 (2018), 167–177, 10.1016/j.nicl.2018.01.019.
Caroli, A., Prestia, A., Chen, K., Ayutyanont, N., Landau, S.M., Madison, C.M., Alzheimer's Disease Neuroimaging, I. Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: Head-to-head comparison. Journal of Nuclear Medicine 53:4 (2012), 592–600, 10.2967/jnumed.111.094946.
Chase, T.N., Foster, N.L., Mansi, L., Alzheimer's disease and the parietal lobe. Lancet, 2(8343), 1983, 225, 10.1016/s0140-6736(83)90211-8.
Chen, K., Langbaum, J.B., Fleisher, A.S., Ayutyanont, N., Reschke, C., Lee, W., Alzheimer's Disease Neuroimaging, I. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative. NeuroImage 51:2 (2010), 654–664, 10.1016/j.neuroimage.2010.02.064.
Chetelat, G., Desgranges, B., Landeau, B., Mezenge, F., Poline, J.B., de la Sayette, V., Baron, J.C., Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain: a Journal of Neurology 131:Pt 1 (2008), 60–71, 10.1093/brain/awm288.
Chetelat, G., Ossenkoppele, R., Villemagne, V.L., Perrotin, A., Landeau, B., Mezenge, F., Rabinovici, G.D., Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain: a Journal of Neurology 139:Pt 9 (2016), 2528–2539, 10.1093/brain/aww159.
Cohen, A.D., Price, J.C., Weissfeld, L.A., James, J., Rosario, B.L., Bi, W., Klunk, W.E., Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: An example of brain reserve. The Journal of Neuroscience: the Official Journal of the Society for Neuroscience 29:47 (2009), 14770–14778, 10.1523/JNEUROSCI.3669-09.2009.
Collette, F., Van der Linden, M., Salmon, E., Executive dysfunction in Alzheimer's disease. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 35:1 (1999), 57–72 http://hdl.handle.net/2268/3743.
de Leon, M.J., Convit, A., Wolf, O.T., Tarshish, C.Y., DeSanti, S., Rusinek, H., Fowler, J., Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proceedings of the National Academy of Sciences of the United States of America 98:19 (2001), 10966–10971, 10.1073/pnas.191044198.
De Santi, S., de Leon, M.J., Rusinek, H., Convit, A., Tarshish, C.Y., Roche, A., Fowler, J., Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiology of Aging 22:4 (2001), 529–539, 10.1016/s0197-4580(01)00230-5.
Desgranges, B., Baron, J.C., Giffard, B., Chetelat, G., Lalevee, C., Viader, F., Eustache, F., The neural basis of intrusions in free recall and cued recall: A PET study in Alzheimer's disease. NeuroImage 17:3 (2002), 1658–1664.
Desgranges, B., Baron, J.C., Lalevee, C., Giffard, B., Viader, F., de La Sayette, V., Eustache, F., The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: Relationship to degree of deterioration. Brain: a Journal of Neurology 125:Pt 5 (2002), 1116–1124.
Didic, M., Felician, O., Gour, N., Bernard, R., Pecheux, C., Mundler, O., Guedj, E., Rhinal hypometabolism on FDG PET in healthy APO-E4 carriers: Impact on memory function and metabolic networks. European Journal of Nuclear Medicine and Molecular Imaging 42:10 (2015), 1512–1521, 10.1007/s00259-015-3057-y.
Duan, J., Liu, Y., Wu, H., Wang, J., Chen, L., Chen, C.L.P., Broad learning for early diagnosis of Alzheimer's disease using FDG-PET of the brain. Frontiers in Neuroscience, 17, 2023, 1137567, 10.3389/fnins.2023.1137567.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., Alzheimer's Disease Neuroimaging, I. Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease. NeuroImage: Clinical 3 (2013), 84–94, 10.1016/j.nicl.2013.07.005.
Foster, N.L., Heidebrink, J.L., Clark, C.M., Jagust, W.J., Arnold, S.E., Barbas, N.R., Minoshima, S., FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain: a Journal of Neurology 130:Pt 10 (2007), 2616–2635, 10.1093/brain/awm177.
Friston, K.J., Frith, C.D., Liddle, P.F., Frackowiak, R.S., Comparing functional (PET) images: The assessment of significant change. Journal of Cerebral Blood Flow and Metabolism 11:4 (1991), 690–699, 10.1038/jcbfm.1991.122.
Gerretsen, P., Chung, J.K., Shah, P., Plitman, E., Iwata, Y., Caravaggio, F., Alzheimer's Disease Neuroimaging, I. Anosognosia is an independent predictor of conversion from mild cognitive impairment to Alzheimer's disease and is associated with reduced brain metabolism. Journal of Clinical Psychiatry 78:9 (2017), e1187–e1196, 10.4088/JCP.16m11367.
Grothe, M.J., Heinsen, H., Amaro, E. Jr., Grinberg, L.T., Teipel, S.J., Cognitive correlates of basal forebrain atrophy and associated cortical hypometabolism in mild cognitive impairment. Cerebral Cortex 26:6 (2016), 2411–2426, 10.1093/cercor/bhv062.
Grothe, M.J., Moscoso, A., Silva-Rodriguez, J., Lange, C., Nho, K., Saykin, A.J., Alzheimer's Disease Neuroimaging, I. Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 19:4 (2023), 1234–1244, 10.1002/alz.12763.
Grothe, M.J., Teipel, S.J., Alzheimer's Disease Neuroimaging, I. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks. Human Brain Mapping 37:1 (2016), 35–53, 10.1002/hbm.23018.
Guerrier, L., Le Men, J., Gane, A., Planton, M., Salabert, A.S., Payoux, P., Pariente, J., Involvement of the cingulate cortex in anosognosia: A multimodal neuroimaging study in Alzheimer's disease patients. Journal of Alzheimer's Disease 65:2 (2018), 443–453, 10.3233/JAD-180324.
Habeck, C., Risacher, S., Lee, G.J., Glymour, M.M., Mormino, E., Mukherjee, S., Alzheimer's Disease Neuroimaging, I. Relationship between baseline brain metabolism measured using [(1)(8)F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging and Behavior 6:4 (2012), 568–583, 10.1007/s11682-012-9208-x.
Haxby, J.V., Grady, C.L., Koss, E., Horwitz, B., Heston, L., Schapiro, M., Rapoport, S.I., Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Archives of Neurology 47:7 (1990), 753–760, 10.1001/archneur.1990.00530070043010.
Herholz, K., Imaging clinical subtypes and associated brain networks in Alzheimer's disease. Brain Sciences, 12(2), 2022, 10.3390/brainsci12020146.
Herholz, K., Salmon, E., Perani, D., Baron, J.C., Holthoff, V., Frolich, L., Heiss, W.D., Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage 17:1 (2002), 302–316.
Hoilund-Carlsen, P.F., Alavi, A., Revheim, M.E., Re: Aducanumab-related ARIA: Paean or lament?. Clinical Nuclear Medicine 48:6 (2023), 505–506, 10.1097/RLU.0000000000004509.
Iaccarino, L., Sala, A., Perani, D., Alzheimer's Disease Neuroimaging, I. Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Annals of Clinical and Translational Neurology 6:6 (2019), 1113–1120, 10.1002/acn3.782.
Ibanez, V., Pietrini, P., Alexander, G.E., Furey, M.L., Teichberg, D., Rajapakse, J.C., Horwitz, B., Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 50:6 (1998), 1585–1593, 10.1212/wnl.50.6.1585.
Inui, Y., Ito, K., Kato, T., Group, S.-J.S., Longer-term investigation of the value of 18F-FDG-PET and magnetic resonance imaging for predicting the conversion of mild cognitive impairment to Alzheimer's disease: A multicenter study. Journal of Alzheimer's Disease 60:3 (2017), 877–887, 10.3233/JAD-170395.
Isella, V., Rosazza, C., Ferri, F., Gazzotti, M., Impagnatiello, V., Mapelli, C., Ferrarese, C., Learning from mistakes: Cognitive and metabolic correlates of errors on picture naming in the Alzheimer's disease spectrum. Journal of Alzheimer's Disease 87:3 (2022), 1033–1053, 10.3233/JAD-220053.
Ishii, K., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H., Mori, E., Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 9:6 (1998), 317–322, 10.1159/000017083.
Ishii, K., Willoch, F., Minoshima, S., Drzezga, A., Ficaro, E.P., Cross, D.J., Schwaiger, M., Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: Validation of anatomic standardization for atrophied brains. Journal of Nuclear Medicine 42:4 (2001), 548–557.
Jack, C.R. Jr., Bennett, D.A., Blennow, K., Carrillo, M.C., Dunn, B., Haeberlein, S.B., Contributors. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 14:4 (2018), 535–562, 10.1016/j.jalz.2018.02.018.
Jack, C.R. Jr., Knopman, D.S., Jagust, W.J., Petersen, R.C., Weiner, M.W., Aisen, P.S., Trojanowski, J.Q., Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurology 12:2 (2013), 207–216, 10.1016/S1474-4422(12)70291-0.
Jagust, W., Bandy, D., Chen, K., Foster, N.L., Landau, S.M., Mathis, C.A., Alzheimer's Disease Neuroimaging, I. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 6:3 (2010), 221–229, 10.1016/j.jalz.2010.03.003.
Jagust, W., Gitcho, A., Sun, F., Kuczynski, B., Mungas, D., Haan, M., Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Annals of Neurology 59:4 (2006), 673–681, 10.1002/ana.20799.
Jedidi, H., Feyers, D., Collette, F., Bahri, M.A., Jaspar, M., d'Argembeau, A., Bastin, C., Dorsomedial prefrontal metabolism and unawareness of current characteristics of personality traits in Alzheimer's disease. Social Cognitive and Affective Neuroscience, 2013, 10.1093/scan/nst132.
Jellinger, K.A., Neuropathological assessment of the Alzheimer spectrum. Journal of Neural Transmission (Vienna) 127:9 (2020), 1229–1256, 10.1007/s00702-020-02232-9.
Jeong, S.H., Cha, J., Yoo, H.S., Chung, S.J., Jung, J.H., Sohn, Y.H., Lee, P.H., Different effect of hypo- and hypermetabolism on cognition in dementia with Lewy bodies: Are they coupled or independent?. NPJ Parkinson's Disease, 10(1), 2024, 4, 10.1038/s41531-023-00622-w.
Joubert, S., Gour, N., Guedj, E., Didic, M., Gueriot, C., Koric, L., Ceccaldi, M., Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 74 (2016), 217–232, 10.1016/j.cortex.2015.10.014.
Kang, S., Jeon, S., Lee, Y.G., Ye, B.S., Alteration of medial temporal lobe metabolism related to Alzheimer's disease and dementia with lewy bodies. Alzheimer's Research & Therapy, 16(1), 2024, 89, 10.1186/s13195-024-01429-4.
Khosravi, M., Peter, J., Wintering, N.A., Serruya, M., Shamchi, S.P., Werner, T.J., Newberg, A.B., 18F-FDG is a superior indicator of cognitive performance compared to 18F-Florbetapir in Alzheimer's disease and mild cognitive impairment evaluation: A global quantitative analysis. Journal of Alzheimer's Disease 70:4 (2019), 1197–1207, 10.3233/JAD-190220.
Kishore, N., Goel, N., Deep learning based diagnosis of Alzheimer's disease using FDG-PET images. Neuroscience Letters, 817, 2023, 137530, 10.1016/j.neulet.2023.137530.
Knopman, D.S., Jack, C.R. Jr., Wiste, H.J., Weigand, S.D., Vemuri, P., Lowe, V.J., Petersen, R.C., Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Annals of Neurology 73:4 (2013), 472–480, 10.1002/ana.23816.
Lekeu, F., Van der Linden, M., Chicherio, C., Collette, F., Degueldre, C., Franck, G., Salmon, E., Brain correlates of performance in a free/cued recall task with semantic encoding in Alzheimer disease. Alzheimer Disease and Associated Disorders 17:1 (2003), 35–45.
Lekeu, F., Van der Linden, M., Degueldre, C., Lemaire, C., Luxen, A., Franck, G., Salmon, E., Effects of Alzheimer's disease on the recognition of novel versus familiar words: Neuropsychological and clinico-metabolic data. Neuropsychology 17:1 (2003), 143–154.
Levin, F., Ferreira, D., Lange, C., Dyrba, M., Westman, E., Buchert, R., Alzheimer's Disease Neuroimaging, I. Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration. Alzheimer's Research & Therapy, 13(1), 2021, 49, 10.1186/s13195-021-00785-9.
Ma, H.R., Sheng, L.Q., Pan, P.L., Wang, G.D., Luo, R., Shi, H.C., Zhong, J.G., Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer's dementia: A meta-analysis. Translational Neurodegeneration, 7, 2018, 9, 10.1186/s40035-018-0114-z.
McKay, N.S., Gordon, B.A., Hornbeck, R.C., Dincer, A., Flores, S., Keefe, S.J., Dominantly Inherited Alzheimer, N. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience 26:8 (2023), 1449–1460, 10.1038/s41593-023-01359-8.
McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr., Kawas, C.H., Phelps, C.H., The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia: the Journal of the Alzheimer's Association 7:3 (2011), 263–269, 10.1016/j.jalz.2011.03.005.
Mehta, R.I., Schneider, J.A., What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia. Current Opinion in Neurology 34:2 (2021), 237–245, 10.1097/WCO.0000000000000912.
Minoshima, S., Frey, K.A., Koeppe, R.A., Foster, N.L., Kuhl, D.E., A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. Journal of Nuclear Medicine 36:7 (1995), 1238–1248.
Mosconi, L., Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. European Journal of Nuclear Medicine and Molecular Imaging 32:4 (2005), 486–510, 10.1007/s00259-005-1762-7.
Mosconi, L., Berti, V., Glodzik, L., Pupi, A., De Santi, S., de Leon, M.J., Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. Journal of Alzheimer's Disease 20:3 (2010), 843–854, 10.3233/JAD-2010-091504.
Mosconi, L., De Santi, S., Brys, M., Tsui, W.H., Pirraglia, E., Glodzik-Sobanska, L., de Leon, M.J., Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biological Psychiatry 63:6 (2008), 609–618, 10.1016/j.biopsych.2007.05.030.
Mosconi, L., Sorbi, S., Nacmias, B., De Cristofaro, M.T., Fayyaz, M., Cellini, E., Pupi, A., Brain metabolic differences between sporadic and familial Alzheimer's disease. Neurology 61:8 (2003), 1138–1140, 10.1212/01.wnl.0000086816.30011.75.
Mosconi, L., Tsui, W.H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., de Leon, M.J., Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. Journal of Nuclear Medicine 49:3 (2008), 390–398, 10.2967/jnumed.107.045385.
Mutlu, J., Landeau, B., Tomadesso, C., de Flores, R., Mezenge, F., de La Sayette, V., Chetelat, G., Connectivity disruption, atrophy, and hypometabolism within posterior cingulate networks in Alzheimer's disease. Frontiers in Neuroscience, 10, 2016, 582, 10.3389/fnins.2016.00582.
Na, S., Kang, D.W., Kim, G.H., Kim, K.W., Kim, Y., Kim, H.J., Korean Dementia, A. The usefulness of (18)F-FDG PET to differentiate subtypes of dementia: The systematic review and meta-analysis. Dementia and Neurocognitive Disorders 23:1 (2024), 54–66, 10.12779/dnd.2024.23.1.54.
Nelson, P.T., Dickson, D.W., Trojanowski, J.Q., Jack, C.R., Boyle, P.A., Arfanakis, K., Schneider, J.A., Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report. Brain: a Journal of Neurology 142:6 (2019), 1503–1527, 10.1093/brain/awz099.
Nestor, P.J., Fryer, T.D., Ikeda, M., Hodges, J.R., Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). The European Journal of Neuroscience 18:9 (2003), 2663–2667, 10.1046/j.1460-9568.2003.02999.x.
Ng, S., Villemagne, V.L., Berlangieri, S., Lee, S.T., Cherk, M., Gong, S.J., Rowe, C.C., Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. Journal of Nuclear Medicine 48:4 (2007), 547–552, 10.2967/jnumed.106.037762.
Ossenkoppele, R., Madison, C., Oh, H., Wirth, M., van Berckel, B.N., Jagust, W.J., Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function?. Cerebral Cortex 24:8 (2014), 2210–2218, 10.1093/cercor/bht076.
Perani, D., Bressi, S., Cappa, S.F., Vallar, G., Alberoni, M., Grassi, F., Fazio, F., Evidence of multiple memory systems in the human brain. A [18F]FDG PET metabolic study. Brain: a Journal of Neurology 116:Pt 4 (1993), 903–919, 10.1093/brain/116.4.903.
Perovnik, M., Tomse, P., Jamsek, J., Emersic, A., Tang, C., Eidelberg, D., Trost, M., Identification and validation of Alzheimer's disease-related metabolic brain pattern in biomarker confirmed Alzheimer's dementia patients. Scientific Reports, 12(1), 2022, 11752, 10.1038/s41598-022-15667-9.
Perrotin, A., Desgranges, B., Landeau, B., Mezenge, F., La Joie, R., Egret, S., Chetelat, G., Anosognosia in Alzheimer disease: Disconnection between memory and self-related brain networks. Annals of Neurology 78:3 (2015), 477–486, 10.1002/ana.24462.
Presotto, L., Ballarini, T., Caminiti, S.P., Bettinardi, V., Gianolli, L., Perani, D., Validation of (18)F-FDG-PET single-subject optimized SPM procedure with different PET scanners. Neuroinformatics 15:2 (2017), 151–163, 10.1007/s12021-016-9322-9.
Reiman, E.M., Caselli, R.J., Yun, L.S., Chen, K., Bandy, D., Minoshima, S., Osborne, D., Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. The New England Journal of Medicine 334:12 (1996), 752–758, 10.1056/NEJM199603213341202.
Rogeau, A., Hives, F., Bordier, C., Lahousse, H., Roca, V., Lebouvier, T., Lopes, R., A 3D convolutional neural network to classify subjects as Alzheimer's disease, frontotemporal dementia or healthy controls using brain 18F-FDG PET. NeuroImage, 288, 2024, 120530, 10.1016/j.neuroimage.2024.120530.
Rubinski, A., Franzmeier, N., Neitzel, J., Ewers, M., Alzheimer's Disease Neuroimaging, I. FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels. Alzheimer's Research & Therapy, 12(1), 2020, 133, 10.1186/s13195-020-00702-6.
Sala, A., Caprioglio, C., Santangelo, R., Vanoli, E.G., Iannaccone, S., Magnani, G., Perani, D., Brain metabolic signatures across the Alzheimer's disease spectrum. European Journal of Nuclear Medicine and Molecular Imaging 47:2 (2020), 256–269, 10.1007/s00259-019-04559-2.
Salmon, E., Kerrouche, N., Perani, D., Lekeu, F., Holthoff, V., Beuthien-Baumann, B., Herholz, K., On the multivariate nature of brain metabolic impairment in Alzheimer's disease. Neurobiology of Aging 30:2 (2009), 186–197.
Salmon, E., Meyer, F., Genon, S., Collette, F., Bastin, C., Neural correlates of impaired cognitive processes underlying self-unawareness in Alzheimer's disease. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 171 (2024), 1–12, 10.1016/j.cortex.2023.10.009.
Salmon, E., Perani, D., Herholz, K., Marique, P., Kalbe, E., Holthoff, V., Garraux, G., Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Human Brain Mapping 27:7 (2006), 588–597.
Scheef, L., Spottke, A., Daerr, M., Joe, A., Striepens, N., Kolsch, H., Jessen, F., Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology 79:13 (2012), 1332–1339, 10.1212/WNL.0b013e31826c1a8d.
Schroeter, M.L., Stein, T., Maslowski, N., Neumann, J., Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients. NeuroImage 47:4 (2009), 1196–1206, 10.1016/j.neuroimage.2009.05.037.
Serrano-Pozo, A., Frosch, M.P., Masliah, E., Hyman, B.T., Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 1(1), 2011, a006189, 10.1101/cshperspect.a006189.
Silverman, D.H., Small, G.W., Chang, C.Y., Lu, C.S., Kung De Aburto, M.A., Chen, W., Phelps, M.E., Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA 286:17 (2001), 2120–2127.
Smailagic, N., Lafortune, L., Kelly, S., Hyde, C., Brayne, C., 18F-FDG PET for prediction of conversion to Alzheimer's disease dementia in people with mild cognitive impairment: An updated systematic review of test accuracy. Journal of Alzheimer's Disease 64:4 (2018), 1175–1194, 10.3233/JAD-171125.
Tahmasian, M., Pasquini, L., Scherr, M., Meng, C., Forster, S., Mulej Bratec, S., Drzezga, A., The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease. Neurology 84:19 (2015), 1956–1963, 10.1212/WNL.0000000000001575.
Tanner, J.A., Iaccarino, L., Edwards, L., Asken, B.M., Gorno-Tempini, M.L., Kramer, J.H., Rabinovici, G.D., Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease. Brain: a Journal of Neurology 145:12 (2022), 4489–4505, 10.1093/brain/awac229.
Tomadesso, C., Perrotin, A., Mutlu, J., Mezenge, F., Landeau, B., Egret, S., Chetelat, G., Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment. NeuroImage: Clinical 8 (2015), 473–482, 10.1016/j.nicl.2015.05.010.
Tondo, G., Boccalini, C., Vanoli, E.G., Presotto, L., Muscio, C., Ciullo, V., Network, A. D. p. Brain metabolism and amyloid load in individuals with subjective cognitive decline or pre-mild cognitive impairment. Neurology 99:3 (2022), e258–e269, 10.1212/WNL.0000000000200351.
Tondo, G., Carli, G., Santangelo, R., Mattoli, M.V., Presotto, L., Filippi, M., Alzheimer's Disease Neuroimaging, I. Biomarker-based stability in limbic-predominant amnestic mild cognitive impairment. European Journal of Neurology: the Official Journal of the European Federation of Neurological Societies 28:4 (2021), 1123–1133, 10.1111/ene.14639.
Trejo-Lopez, J.A., Yachnis, A.T., Prokop, S., Neuropathology of Alzheimer's disease. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 19:1 (2022), 173–185, 10.1007/s13311-021-01146-y.
Vanhoutte, M., Semah, F., Rollin Sillaire, A., Jaillard, A., Petyt, G., Kuchcinski, G., Lopes, R., (18)F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's disease. Neurobiology of Aging 59 (2017), 184–196, 10.1016/j.neurobiolaging.2017.08.009.
Villain, N., Fouquet, M., Baron, J.C., Mezenge, F., Landeau, B., de La Sayette, V., Chetelat, G., Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain: a Journal of Neurology 133:11 (2010), 3301–3314.
Woodward, M.C., Rowe, C.C., Jones, G., Villemagne, V.L., Varos, T.A., Differentiating the frontal presentation of Alzheimer's disease with FDG-PET. Journal of Alzheimer's Disease 44:1 (2015), 233–242, 10.3233/JAD-141110.
Yakushev, I., Landvogt, C., Buchholz, H.G., Fellgiebel, A., Hammers, A., Scheurich, A., Bartenstein, P., Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Research 164:2 (2008), 143–153, 10.1016/j.pscychresns.2007.11.004.
Yang, Z., Cummings, J.L., Kinney, J.W., Cordes, D., Alzheimer's Disease Neuroimaging, I. Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients. Frontiers in Neuroscience, 17, 2023, 1151820, 10.3389/fnins.2023.1151820.
Yee, E., Popuri, K., Beg, M.F., Alzheimer's Disease Neuroimaging, I. Quantifying brain metabolism from FDG-PET images into a probability of Alzheimer's dementia score. Human Brain Mapping 41:1 (2020), 5–16, 10.1002/hbm.24783.
